| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.814 | 4.605 | - | - | - | - | - | - | - | - |
| Total Income - EUR | 25.815 | 4.605 | - | - | - | - | - | - | - | - |
| Total Expenses - EUR | 27.613 | 9.223 | - | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -1.799 | -4.619 | - | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -2.573 | -4.665 | - | - | - | - | - | - | - | - |
| Employees | 3 | 0 | - | - | - | - | - | - | - | - |
Check the financial reports for the company - Dasimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.838 | 6.698 | - | - | - | - | - | - | - | - |
| Current Assets | 1.464 | 1 | - | - | - | - | - | - | - | - |
| Inventories | 0 | 0 | - | - | - | - | - | - | - | - |
| Receivables | 110 | 0 | - | - | - | - | - | - | - | - |
| Cash | 1.353 | 1 | - | - | - | - | - | - | - | - |
| Shareholders Funds | 5.651 | 929 | - | - | - | - | - | - | - | - |
| Social Capital | 4.499 | 4.454 | - | - | - | - | - | - | - | - |
| Debts | 3.650 | 5.770 | - | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | - | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dasimed S.r.l.